| |
|
|
|
ASLAN Pharmaceuticals Limited  
|
|
0.44 0.03 (0.07%) |
11-21 15:59 |
|
Open: |
0.4437 |
Pre close: |
0.41 |
Target:
|
2.14
|
|
High: |
0.458 |
Low: |
0.38 |
Resistance:
|
1.83
2.75
|
|
Volume: |
133,084 |
Market Cap: |
26M |
Support:
|
0.35
0.29
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
0.42
 |
MACD |
MACD(12,26):
|
-0.36 |
|
MA(20): |
1.20 |
Signal(12,26,9): |
-0.26 |
|
MA(100): |
2.09 |
Stochastic Oscillator |
%K(14,3):
|
2.89  |
|
MA(250): |
3.13 |
%D(3): |
2.82 |
|
Average Volume(K) |
3-Month: |
4230
|
52-Week |
High:
|
6.48 |
|
10-Days: |
15005 |
Low: |
0.35 |
|
RSI |
RSI(14):
|
28.25 |
Change(%): |
-91.8 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.855 |
Return on Equity (ttm) |
-99.7 |
Shares Out. (M) |
32.05 |
|
EPS Est. Current Year |
0.000 |
Return on Assets (ttm) |
-36.2 |
Shares Float (M) |
28.15 |
|
EPS Est. Next Year |
0.000 |
PEG Ratio |
0.00 |
% Held by Insiders |
0.00 |
|
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
9.35 |
|
Forward EPS |
0.000 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
38 |
|
Book Value (p.s.) |
0.410 |
EBITDA (p.s.) |
-0.817 |
P/E |
-0.49 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
1.02 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-29.20 |
P/S |
4.66 |
|
Operating Margin |
-879.37 |
Levered Free Cash Flow
(M) |
-19.22 |
P/CF |
-0.46 |
|
|
|
|
|
|
